ScholarIQanswers from OpenAlex

Use of dipeptidyl peptidase-4 inhibitors for type 2 diabetes mellitus and risk of fracture

PaperCitations, authors & open-access status

Use of dipeptidyl peptidase-4 inhibitors for type 2 diabetes mellitus and risk of fracture is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Use of dipeptidyl peptidase-4 inhibitors for type 2 diabetes mellitus and risk of fracture have?

ScholarIQcitation count

Use of dipeptidyl peptidase-4 inhibitors for type 2 diabetes mellitus and risk of fracture has 68 citations in the OpenAlex counts ScholarIQ stores.

When was Use of dipeptidyl peptidase-4 inhibitors for type 2 diabetes mellitus and risk of fracture published?

ScholarIQyear

Use of dipeptidyl peptidase-4 inhibitors for type 2 diabetes mellitus and risk of fracture has 2014 year in the ScholarIQ index.

What is the open-access status of Use of dipeptidyl peptidase-4 inhibitors for type 2 diabetes mellitus and risk of fracture?

ScholarIQoa status

Use of dipeptidyl peptidase-4 inhibitors for type 2 diabetes mellitus and risk of fracture has closed oa status in the ScholarIQ index.

What is the DOI of Use of dipeptidyl peptidase-4 inhibitors for type 2 diabetes mellitus and risk of fracture?

ScholarIQdoi

The DOI for Use of dipeptidyl peptidase-4 inhibitors for type 2 diabetes mellitus and risk of fracture is on the source record.

What is the PMID of Use of dipeptidyl peptidase-4 inhibitors for type 2 diabetes mellitus and risk of fracture?

ScholarIQpmid

The PMID for Use of dipeptidyl peptidase-4 inhibitors for type 2 diabetes mellitus and risk of fracture is on the source record.

What is the OpenAlex record for Use of dipeptidyl peptidase-4 inhibitors for type 2 diabetes mellitus and risk of fracture?

ScholarIQopenalex

The OpenAlex for Use of dipeptidyl peptidase-4 inhibitors for type 2 diabetes mellitus and risk of fracture is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial